| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, Phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Chain A, Class I phosphodiesterase PDEB1 | 0 | 1 | 0 | 1 |
| Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
| Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 14 | 0 | 0 | 14 |
| thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
| estrogen-related nuclear receptor alpha | 39 | 0 | 0 | 39 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
| geminin | 42 | 0 | 0 | 42 |
| cytochrome P450 3A4 isoform 1 | 17 | 0 | 0 | 17 |
| histone acetyltransferase KAT2A isoform 1 | 17 | 0 | 0 | 17 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 17 | 0 | 0 | 17 |
| Monocarboxylate transporter 4 | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 6 | 0 | 7 |
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 3 | 0 | 3 |
| Renin | 0 | 2 | 1 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit delta | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 17 | 1 | 0 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 17 | 0 | 0 | 17 |
| Adenosine receptor A1 | 0 | 3 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 17 | 0 | 0 | 17 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Adenosine receptor A2b | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 17 | 0 | 0 | 17 |
| Adenosine receptor A1 | 0 | 1 | 1 | 4 |
| Adenosine receptor A2a | 0 | 3 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 7 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 4 | 0 | 5 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 4 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 17 | 0 | 0 | 17 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 4 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 5 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 9 | 1 | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 9 | 1 | 11 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 4 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 3 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 4 | 0 | 5 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 4 | 0 | 5 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 3 | 0 | 3 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| GABA theta subunit | 17 | 0 | 0 | 17 |
| Phosphodiesterase | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 17 | 0 | 0 | 17 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 2 | 0 | 2 |
| Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
| Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
| Reverse transcriptase/RNaseH | 0 | 2 | 0 | 3 |
| Integrase | 0 | 5 | 0 | 5 |
| TDP1 protein | 46 | 0 | 0 | 46 |
| chromobox protein homolog 1 | 36 | 0 | 0 | 36 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 3 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
| RAR-related orphan receptor gamma | 31 | 0 | 0 | 31 |
| GLI family zinc finger 3 | 33 | 0 | 0 | 33 |
| AR protein | 42 | 0 | 0 | 42 |
| aldehyde dehydrogenase 1 family, member A1 | 33 | 0 | 0 | 33 |
| retinoic acid nuclear receptor alpha variant 1 | 32 | 0 | 0 | 32 |
| retinoid X nuclear receptor alpha | 28 | 0 | 0 | 28 |
| estrogen nuclear receptor alpha | 44 | 0 | 0 | 44 |
| peroxisome proliferator-activated receptor delta | 21 | 0 | 0 | 21 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
| activating transcription factor 6 | 11 | 0 | 0 | 11 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| Histone H2A.x | 14 | 0 | 0 | 14 |
| thyroid hormone receptor beta isoform a | 15 | 0 | 0 | 15 |
| heat shock protein beta-1 | 8 | 0 | 0 | 8 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 33 | 0 | 0 | 33 |
| lamin isoform A-delta10 | 32 | 0 | 0 | 32 |
| Voltage-dependent calcium channel gamma-2 subunit | 18 | 0 | 0 | 18 |
| Glutamate receptor 2 | 19 | 0 | 0 | 19 |
| Ribonucleoside-diphosphate reductase subunit M2 | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Luciferase | 15 | 0 | 0 | 15 |
| pregnane X receptor | 10 | 0 | 0 | 10 |
| phosphopantetheinyl transferase | 19 | 0 | 0 | 19 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| Microtubule-associated protein tau | 17 | 0 | 0 | 17 |
| caspase 7, apoptosis-related cysteine protease | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 3 | 30 | 0 | 0 | 30 |
| farnesoid X nuclear receptor | 18 | 0 | 0 | 18 |
| pregnane X nuclear receptor | 27 | 0 | 0 | 27 |
| peroxisome proliferator activated receptor gamma | 22 | 0 | 0 | 22 |
| caspase-3 | 7 | 0 | 0 | 7 |
| euchromatic histone-lysine N-methyltransferase 2 | 44 | 0 | 0 | 44 |
| aryl hydrocarbon receptor | 16 | 0 | 0 | 16 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
| Cellular tumor antigen p53 | 29 | 0 | 0 | 29 |
| Cytochrome P450 1A2 | 0 | 3 | 1 | 4 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Adenosine receptor A3 | 0 | 5 | 0 | 5 |
| Alpha-1B adrenergic receptor | 0 | 8 | 0 | 8 |
| Acetylcholinesterase | 0 | 5 | 0 | 6 |
| Sodium-dependent noradrenaline transporter | 0 | 7 | 0 | 7 |
| Aryl hydrocarbon receptor | 0 | 0 | 2 | 2 |
| Alpha-1A adrenergic receptor | 0 | 8 | 0 | 8 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 8 | 1 | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 6 | 0 | 6 |
| vitamin D3 receptor isoform VDRA | 17 | 0 | 0 | 17 |
| peripheral myelin protein 22 | 23 | 0 | 0 | 23 |
| ATP-binding cassette sub-family C member 3 | 0 | 24 | 0 | 24 |
| Multidrug resistance-associated protein 4 | 0 | 24 | 0 | 25 |
| Bile salt export pump | 0 | 30 | 0 | 30 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 2 | 1 | 4 |
| Oxytocin receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 0 | 3 | 3 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
| Translocator protein | 0 | 1 | 0 | 2 |
| Oxytocin receptor | 0 | 1 | 1 | 2 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 25 | 0 | 26 |
| Chain A, 2-oxoglutarate Oxygenase | 19 | 0 | 0 | 19 |
| glucocorticoid receptor [Homo sapiens] | 27 | 0 | 0 | 27 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 5 | 0 | 0 | 5 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 9 | 6 | 19 |
| Muscarinic acetylcholine receptor M4 | 0 | 10 | 5 | 18 |
| Muscarinic acetylcholine receptor M1 | 0 | 9 | 3 | 17 |
| Muscarinic acetylcholine receptor M3 | 0 | 8 | 3 | 15 |
| Muscarinic acetylcholine receptor M4 | 0 | 8 | 2 | 14 |
| Muscarinic acetylcholine receptor M5 | 0 | 8 | 2 | 14 |
| Muscarinic acetylcholine receptor M5 | 0 | 6 | 5 | 14 |
| Muscarinic acetylcholine receptor M2 | 0 | 9 | 2 | 16 |
| Muscarinic acetylcholine receptor M1 | 0 | 9 | 7 | 20 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 4 | 7 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 5 | 13 |
| Alpha-1D adrenergic receptor | 0 | 2 | 1 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 1 | 3 |
| Histamine H2 receptor | 14 | 0 | 1 | 16 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 4 | 1 | 5 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 28 | 0 | 0 | 28 |
| Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
| interleukin 8 | 6 | 0 | 0 | 6 |
| ATAD5 protein, partial | 18 | 0 | 0 | 18 |
| Fumarate hydratase | 14 | 0 | 0 | 14 |
| NFKB1 protein, partial | 10 | 0 | 0 | 10 |
| PPM1D protein | 11 | 0 | 0 | 11 |
| Thrombopoietin | 7 | 0 | 0 | 7 |
| Smad3 | 7 | 0 | 0 | 7 |
| estrogen receptor 2 (ER beta) | 13 | 0 | 0 | 13 |
| progesterone receptor | 15 | 0 | 0 | 15 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 27 | 0 | 0 | 27 |
| polyprotein | 14 | 0 | 0 | 14 |
| 67.9K protein | 15 | 0 | 0 | 15 |
| Parkin | 6 | 0 | 0 | 6 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 17 | 0 | 0 | 17 |
| arylsulfatase A | 16 | 0 | 0 | 16 |
| IDH1 | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
| Bloom syndrome protein isoform 1 | 22 | 0 | 0 | 22 |
| peripheral myelin protein 22 isoform 1 | 10 | 0 | 0 | 10 |
| hemoglobin subunit beta | 4 | 0 | 0 | 4 |
| cellular tumor antigen p53 isoform a | 9 | 0 | 0 | 9 |
| thyroid hormone receptor beta isoform 2 | 28 | 0 | 0 | 28 |
| huntingtin isoform 2 | 8 | 0 | 0 | 8 |
| ras-related protein Rab-9A | 5 | 0 | 0 | 5 |
| serine/threonine-protein kinase mTOR isoform 1 | 9 | 0 | 0 | 9 |
| urokinase-type plasminogen activator precursor | 10 | 0 | 0 | 10 |
| plasminogen precursor | 10 | 0 | 0 | 10 |
| urokinase plasminogen activator surface receptor precursor | 10 | 0 | 0 | 10 |
| muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
| Interferon beta | 21 | 0 | 0 | 21 |
| Integrin beta-3 | 7 | 1 | 0 | 8 |
| Integrin alpha-IIb | 7 | 0 | 0 | 7 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
| Nuclear receptor ROR-gamma | 7 | 1 | 1 | 9 |
| Spike glycoprotein | 13 | 0 | 0 | 13 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 14 | 0 | 0 | 14 |
| Ataxin-2 | 17 | 0 | 0 | 17 |
| ATP-dependent phosphofructokinase | 24 | 0 | 0 | 24 |
| regulator of G-protein signaling 4 | 15 | 0 | 0 | 15 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| nonstructural protein 1 | 11 | 0 | 0 | 11 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 10 | 0 | 0 | 10 |
| survival motor neuron protein isoform d | 16 | 0 | 0 | 16 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 0 | 0 | 6 |
| DNA topoisomerase 1 | 0 | 4 | 3 | 14 |
| DNA topoisomerase 2-alpha | 0 | 6 | 1 | 13 |
| DNA topoisomerase 2-beta | 0 | 2 | 1 | 12 |
| Carbonic anhydrase 1 | 0 | 5 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 6 | 1 | 10 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
| bromodomain adjacent to zinc finger domain 2B | 8 | 0 | 0 | 8 |
| nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
| Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 12 | 0 | 0 | 12 |
| oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
| Thymidine kinase, cytosolic | 0 | 4 | 0 | 6 |
| Thymidine phosphorylase | 0 | 0 | 0 | 2 |
| Thymidylate kinase | 0 | 2 | 0 | 2 |
| Thymidine kinase | 0 | 0 | 0 | 2 |
| Thymidylate kinase | 0 | 2 | 0 | 2 |
| vasopressin V1b receptor | 1 | 0 | 0 | 1 |
| cAMP-dependent protein kinase type I-alpha regulatory subunit | 0 | 0 | 1 | 1 |
| cAMP-dependent protein kinase type II-beta regulatory subunit | 0 | 0 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta isoform 1 | 0 | 0 | 1 | 1 |
| relaxin receptor 1 isoform 1 | 4 | 0 | 0 | 4 |
| relaxin receptor 2 isoform 1 | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
| cAMP-dependent protein kinase catalytic subunit beta isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 10 | 0 | 0 | 10 |
| Chain A, Cruzipain | 7 | 0 | 0 | 7 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 31 | 0 | 0 | 31 |
| 15-lipoxygenase, partial | 13 | 0 | 0 | 13 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
| EWS/FLI fusion protein | 24 | 0 | 0 | 24 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 5 | 0 | 0 | 5 |
| lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 10 | 0 | 0 | 10 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| DNA polymerase iota isoform a (long) | 15 | 0 | 0 | 15 |
| nuclear receptor ROR-gamma isoform 1 | 13 | 0 | 0 | 13 |
| M-phase phosphoprotein 8 | 13 | 0 | 0 | 13 |
| muscleblind-like protein 1 isoform 1 | 8 | 0 | 0 | 8 |
| lethal factor (plasmid) | 6 | 0 | 0 | 6 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 3 | 1 | 4 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 0 | 2 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 1 | 3 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Inositol monophosphatase 1 | 6 | 0 | 0 | 6 |
| DNA topoisomerase 1 | 0 | 2 | 0 | 3 |
| Histone deacetylase 1 | 0 | 4 | 2 | 6 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 1 | 3 |
| Histone deacetylase 2 | 0 | 3 | 2 | 5 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 1 | 3 |
| Histone deacetylase 11 | 0 | 2 | 1 | 3 |
| Histone deacetylase 8 | 0 | 3 | 1 | 4 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 3 | 1 | 4 |
| Histone deacetylase 9 | 0 | 2 | 1 | 3 |
| Histone deacetylase 5 | 0 | 2 | 1 | 3 |
| acetylcholinesterase | 11 | 0 | 0 | 11 |
| GALC protein | 5 | 0 | 0 | 5 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 1 | 8 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 2 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 5 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| endonuclease IV | 10 | 0 | 0 | 10 |
| cytochrome P450 2D6 | 11 | 0 | 0 | 11 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
| Alpha-synuclein | 1 | 2 | 0 | 3 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| cytochrome P450 2C9 precursor | 8 | 0 | 0 | 8 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 7 | 0 | 0 | 7 |
| flap endonuclease 1 | 13 | 0 | 0 | 13 |
| Beta-2 adrenergic receptor | 0 | 4 | 4 | 9 |
| Beta-1 adrenergic receptor | 0 | 4 | 4 | 8 |
| Beta-3 adrenergic receptor | 0 | 3 | 3 | 6 |
| GLS protein | 18 | 0 | 0 | 18 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 4 | 1 | 5 |
| UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
| UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 4 |
| UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
| Amyloid-beta precursor protein | 3 | 2 | 0 | 5 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 5 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
| D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 0 | 5 |
| Alpha-2B adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-2A adrenergic receptor | 0 | 3 | 1 | 4 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 2 | 9 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Lysosomal Pro-X carboxypeptidase | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 2 | 9 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 1 | 9 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 1 | 8 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 1 | 8 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
| Transporter | 0 | 2 | 0 | 2 |
| G | 11 | 0 | 0 | 11 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 5 | 0 | 0 | 5 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Rap guanine nucleotide exchange factor 3 | 5 | 0 | 0 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | 11 | 0 | 0 | 11 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 9 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 2 | 4 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 2 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 1 | 2 |
| Inositol hexakisphosphate kinase 1 | 11 | 0 | 0 | 11 |
| Relaxin receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 11 | 0 | 0 | 11 |
| USP1 protein, partial | 19 | 0 | 0 | 19 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 3 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 3 | 0 | 3 |
| nuclear receptor coactivator 3 isoform a | 0 | 3 | 0 | 3 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 3 | 0 | 5 |
| Cytochrome P450 3A4 | 0 | 7 | 2 | 9 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 1 | 0 | 2 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 2 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 8 | 0 | 0 | 8 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 7 | 0 | 0 | 7 |
| RAD51 | 0 | 1 | 0 | 1 |
| Caspase-7 | 4 | 0 | 0 | 4 |
| caspase-3 | 4 | 0 | 0 | 4 |
| caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
| Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 2 |
| Pantothenate synthetase | 0 | 2 | 0 | 2 |
| Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
| Lysine-specific demethylase 6B | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 4A | 0 | 3 | 1 | 4 |
| Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 2 | 2 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 7 | 0 | 0 | 7 |
| Lysine-specific demethylase 6A | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 5C | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 2B | 0 | 1 | 0 | 1 |
| Deoxyhypusine hydroxylase | 0 | 2 | 0 | 2 |
| Lysine-specific demethylase 2A | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 2 | 3 |
| Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
| NAD | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Urease | 0 | 1 | 0 | 1 |
| NAD | 0 | 1 | 0 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
| ATP phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 3 | 2 | 5 |
| TAR DNA-binding protein 43 | 5 | 1 | 0 | 6 |
| Cereblon isoform 4 | 0 | 4 | 0 | 4 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 6 | 1 | 8 |
| ORF73 | 0 | 0 | 1 | 1 |
| Glutamate receptor 1 | 2 | 0 | 0 | 2 |
| Glutamate receptor 3 | 2 | 0 | 0 | 2 |
| Glutamate receptor 4 | 2 | 0 | 0 | 2 |
| Photosystem II protein D1 | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 4 | 0 | 4 |
| Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| Nucleotide-binding oligomerization domain-containing protein 2 | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Proenkephalin-B | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| Delta-type opioid receptor | 0 | 3 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| V-type proton ATPase subunit B, brain isoform | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| RISC-loading complex subunit TARBP2 | 0 | 0 | 1 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 5 | 0 | 0 | 5 |
| tyrosine-protein kinase Yes | 3 | 0 | 0 | 3 |
| Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 2 | 1 | 3 |
| Histone deacetylase-like amidohydrolase | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| Histone deacetylase | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 2 | 0 | 2 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 13 | 0 | 0 | 13 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
| thioredoxin glutathione reductase | 6 | 0 | 0 | 6 |
| hypothetical protein, conserved | 5 | 0 | 0 | 5 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
| eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 12 | 0 | 0 | 12 |
| large T antigen | 0 | 2 | 0 | 2 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 1 | 4 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 1 | 4 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 7 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| BRCA1 | 1 | 0 | 0 | 1 |
| P53 | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 7 | 0 | 0 | 7 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 7 | 0 | 0 | 7 |
| Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
| Retinol-binding protein 4 | 0 | 0 | 2 | 2 |
| Prosaposin | 0 | 0 | 1 | 1 |
| Retinoic acid receptor gamma | 0 | 3 | 2 | 8 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 3 | 4 | 7 |
| Alpha-1D adrenergic receptor | 0 | 5 | 0 | 5 |
| Retinoic acid receptor RXR-beta | 0 | 3 | 2 | 5 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-gamma | 0 | 3 | 2 | 5 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 2 | 0 | 2 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| Vpr | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| WRN | 2 | 0 | 0 | 2 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | 5 | 0 | 0 | 5 |
| DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 0 | 2 | 2 |
| Urease subunit alpha | 0 | 2 | 0 | 2 |
| Ribonucleoside-diphosphate reductase large subunit | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
| Urease subunit beta | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 4 | 0 | 6 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| NPYLR7B | 0 | 0 | 4 | 4 |
| hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
| NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 3 | 0 | 0 | 3 |
| tumor susceptibility gene 101 protein | 3 | 0 | 0 | 3 |
| Single-stranded DNA cytosine deaminase | 2 | 0 | 0 | 2 |
| Chain A, BETA-SPECTRIN | 0 | 0 | 1 | 1 |
| Chain A, Phospholipase C Delta-1 | 0 | 0 | 1 | 1 |
| Chain A, Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 1 | 1 |
| Inositol-trisphosphate 3-kinase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 2 | 2 |
| Inositol 1,4,5-trisphosphate receptor type 2 | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 3 | 0 | 1 | 1 | 2 |
| Inositol polyphosphate-5-phosphatase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 1 | 1 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 3 |
| Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 4 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2A6 | 0 | 3 | 1 | 4 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 2 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 2 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 4 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 3 | 1 | 6 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 2 | 2 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 2 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 2 | 1 | 3 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 2 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 2 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 4 |
| Chain A, Probable serine/threonine-protein kinase pknB | 0 | 1 | 0 | 1 |
| nonstructural protein 1 | 0 | 1 | 0 | 1 |
| LANA | 0 | 0 | 0 | 1 |
| phospholipase A2, group III | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
| histone-lysine N-methyltransferase NSD2 isoform 1 | 0 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Proto-oncogene tyrosine-protein kinase ROS | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 1 | 3 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase BTK | 0 | 1 | 0 | 1 |
| NEDD8-activating enzyme E1 regulatory subunit | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
| NEDD8-activating enzyme E1 catalytic subunit | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
| Cannabinoid receptor 2 | 0 | 0 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 2 | 3 |
| Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
| Acid ceramidase | 0 | 2 | 0 | 2 |
| Glucose-dependent insulinotropic receptor | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 0 | 1 | 1 |
| Glucose-dependent insulinotropic receptor | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 0 | 2 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
| Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| MCOLN3 protein | 0 | 0 | 1 | 1 |
| transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor DM1 | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
| Tubulin alpha-1A chain | 0 | 0 | 1 | 2 |
| Tubulin beta chain | 0 | 0 | 1 | 1 |
| Tubulin beta-4A chain | 0 | 1 | 1 | 3 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| Tubulin beta chain | 0 | 1 | 1 | 3 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| Tubulin alpha-3C chain | 0 | 1 | 1 | 3 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Tubulin alpha-1B chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-4A chain | 0 | 1 | 1 | 3 |
| Tubulin beta-4B chain | 0 | 1 | 1 | 3 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Mer | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 1 | 4 |
| Tubulin beta-2A chain | 0 | 1 | 1 | 3 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| Beta-tubulin | 0 | 1 | 0 | 1 |
| Tubulin beta-8 chain | 0 | 1 | 1 | 3 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| Tubulin alpha-3E chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-1A chain | 0 | 1 | 1 | 3 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 1 | 1 | 3 |
| Tubulin beta-6 chain | 0 | 1 | 1 | 3 |
| Tubulin beta-2B chain | 0 | 1 | 1 | 3 |
| Tubulin beta-1 chain | 0 | 1 | 1 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| Chain A, Fatty acid-binding protein, adipocyte | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 4 |
| Toll-like receptor 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, adipocyte | 0 | 2 | 1 | 3 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 3 | 0 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein 5 | 0 | 2 | 1 | 3 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
| Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 3 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| Aldehyde oxidase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Retina-specific copper amine oxidase | 0 | 2 | 0 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
| Tumor necrosis factor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 3 | 0 | 4 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Albumin | 0 | 1 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 3 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL2 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 1 | 2 |
| Protein kinase C beta type | 0 | 1 | 1 | 2 |
| Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
| Protein kinase C alpha type | 0 | 1 | 1 | 2 |
| Protein kinase C eta type | 0 | 0 | 1 | 1 |
| Protein kinase C iota type | 0 | 0 | 1 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 0 | 1 | 1 |
| Protein kinase C zeta type | 0 | 0 | 1 | 1 |
| Protein kinase C delta type | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
| DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Endothelial PAS domain-containing protein 1 | 0 | 0 | 1 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
| Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase F | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 0 | 1 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, germ cell type | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
| G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
| Histamine H3 receptor | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |